Nigerian drugmaker Fidson selected to manufacture generic influenza antiviral
Fidson Healthcare Plc has been selected as one of 11 manufacturers globally to produce a generic version of the influenza antiviral baloxavir marboxil.
Fidson Healthcare Plc has been selected as one of 11 manufacturers globally to produce a generic version of the influenza antiviral baloxavir marboxil.